Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
03/24/2011 | US20110070642 Device and method for isolating and cultivating live cells on a filter or extracting the genetic material thereof |
03/24/2011 | US20110070641 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
03/24/2011 | US20110070629 Method for micropropagation of monocots based on sustained totipotent cell cultures |
03/24/2011 | US20110070623 Self-inactivating helper adenoviruses for the production of high-capactiy recombinant adenoviruses |
03/24/2011 | US20110070615 Compositions and Methods Relating to Anti-IGF-1 Receptor Antibodies |
03/24/2011 | US20110070613 Monoclonal Antibody |
03/24/2011 | US20110070605 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
03/24/2011 | US20110070581 Separation of Leukocytes |
03/24/2011 | US20110070313 Methods of inducing cell differentiation with placental extracts |
03/24/2011 | US20110070280 Method for differentiating embryonic stem cells into cells expressing aqp-1 |
03/24/2011 | US20110070276 Bioactive keratin peptides |
03/24/2011 | US20110070254 Mutations in the influenza a virus ns1 gene and use thereof |
03/24/2011 | US20110070253 Tumour-associated peptides binding to mhc molecules |
03/24/2011 | US20110070251 Cancer vaccine composition |
03/24/2011 | US20110070250 Therapeutical Composition Containing Dentritic Cells and use Thereof |
03/24/2011 | US20110070246 Antibodies Against CDCP1 for the Treatment of Cancer |
03/24/2011 | US20110070243 Compositions and methods for the treatment of tumor of hematopoietic |
03/24/2011 | US20110070239 Anti-ox40l antibodies |
03/24/2011 | US20110070208 Hbv epitope reactive exogenous t cell receptor (tcr) and uses thereof |
03/24/2011 | US20110070207 Therapeutic composition for atopic dermatitis |
03/24/2011 | US20110070206 Methods of applying physical stimuli to cells |
03/24/2011 | US20110070205 Multipotent stem cells and uses thereof |
03/24/2011 | US20110070204 Medium for handling and storing biological tissues of the musculoskeletal system outside an organism |
03/24/2011 | US20110070203 Mesendoderm and mesoderm cell populations |
03/24/2011 | US20110070201 Mucosal or enteral administration of biologically active macromolecules |
03/24/2011 | US20110070192 Method of preparation of novel nucleoside analogs and uses |
03/24/2011 | US20110070191 T cell receptor fusions and conjugates and methods of use there of |
03/24/2011 | US20110070190 Heterocyclic antiviral compounds |
03/24/2011 | US20110070189 Heterocyclic antiviral compounds |
03/24/2011 | US20110070164 Post release modification of viral envelopes |
03/24/2011 | US20110070162 Rna interference mediating small rna molecules |
03/24/2011 | US20110070154 Artificial cells |
03/24/2011 | US20110070153 Artificial cells |
03/24/2011 | CA2781519A1 Coiled coil and/or tether containing protein complexes and uses thereof |
03/24/2011 | CA2774729A1 Antigen specific tolerogenic antigen presenting cells and related uses compositions, methods and systems |
03/24/2011 | CA2774446A1 Hiv-1 antibodies |
03/24/2011 | CA2774193A1 Novel method for producing differentiated cells |
03/24/2011 | CA2772447A1 Steroidogenesis modified cells and methods for screening for endocrine disrupting chemicals |
03/23/2011 | EP2299269A1 Protein fragment complementation assay based on beta-lactamase |
03/23/2011 | EP2298927A2 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
03/23/2011 | EP2298924A2 Improved method for the recovery of non-segmented, negative-stranded RNA viruses from cDNA |
03/23/2011 | EP2298918A2 Regulation of Plant Biomass and Stress Tolerance |
03/23/2011 | EP2298904A1 Xylanases, nucleic acids encoding them and methods for making and using them |
03/23/2011 | EP2298903A2 Alpha-amylase mutants with altered properties |
03/23/2011 | EP2298902A1 Luciferase biosensor |
03/23/2011 | EP2298899A2 CRSP proteins (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor |
03/23/2011 | EP2298898A1 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences |
03/23/2011 | EP2298878A2 Compositions and methods for the diagnosis of cancer |
03/23/2011 | EP2298873A1 Lipolytic enzyme variants |
03/23/2011 | EP2298871A1 Phospholipases, nucleic acids encoding them and methods for making and using them |
03/23/2011 | EP2298867A2 Method of controlling differentiation of embryonic stem (ES) cells by culturing ES cells in the presence of bmp-2 pathway antagonists |
03/23/2011 | EP2298866A1 Artificial kidney precursor and process for production thereof |
03/23/2011 | EP2298865A1 Blood platelet induction method |
03/23/2011 | EP2298864A2 Mesenchymal stem cells and uses therefor |
03/23/2011 | EP2298863A2 Mesenchymal stem cells and uses therefor |
03/23/2011 | EP2298862A2 Mesenchymal stem cells and uses therefor |
03/23/2011 | EP2298861A2 Mesenchymal stem cells and uses therefor |
03/23/2011 | EP2298859A2 Genetically modified host cells and use of same for producing isoprenoid compounds |
03/23/2011 | EP2298858A1 Bed material for cell culture, method for co-culture of cell and co-cultured cell sheet obtainable therefrom |
03/23/2011 | EP2298816A2 Apoptosis induced by an antibody against Her2 |
03/23/2011 | EP2298815A1 B-cell reduction using CD37-specific and CD20-specific binding molecules |
03/23/2011 | EP2298808A1 Anti-C5 antibodies and their therapeutic uses |
03/23/2011 | EP2298806A1 Antibodies that bind cell-associated CA 125/0722P and methods of use thereof |
03/23/2011 | EP2298804A2 Monoclonal antibody production by EBV transformation of B cells |
03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof |
03/23/2011 | EP2298802A1 T1R3 taste receptors and genes encoding same |
03/23/2011 | EP2298793A2 Polypeptide fragments of hepatitis E virus, vaccine composition comprising said fragments and diagnostic kits |
03/23/2011 | EP2298789A1 Mammalian genes; related reagents and methods |
03/23/2011 | EP2298728A1 Transfection reagents |
03/23/2011 | EP2298436A1 Tangential flow filtration devices and methods for leukocyte enrichment |
03/23/2011 | EP2298357A1 Compositions and methods for regulated protein expression in gut |
03/23/2011 | EP2298355A2 Albumin fusion proteins |
03/23/2011 | EP2298346A2 Human antibodies specific to kdr and uses thereof |
03/23/2011 | EP2298343A1 Composition and method for increasing cell density in cell cultures infected with lentivirus |
03/23/2011 | EP2298334A2 Tweak receptor |
03/23/2011 | EP2298333A2 Tweak receptor |
03/23/2011 | EP2298301A2 Medicaments for increasing endogenous Erythropoietin (EPO) |
03/23/2011 | EP2298231A2 Apparatus and methods for providing sex-sorted animal sperm |
03/23/2011 | EP2298067A1 Novel pesticidal toxins |
03/23/2011 | EP2297576A1 Established human brown adipocyte line and method for differentiation from an hmads cell line |
03/23/2011 | EP2297319A1 Growth factors for production of definitive endoderm |
03/23/2011 | EP2297308A2 Anti-tumoral cells |
03/23/2011 | EP2297307A1 Methods for the production of ips cells using non-viral approach |
03/23/2011 | EP2297306A1 Human facilitating cells |
03/23/2011 | EP2297305A2 Isolation of stem cell precursors and expansion in non-adherent conditions |
03/23/2011 | EP2297304A1 Human bone-forming cells in the treatment of conditions and bone diseases associated with immunodeficiency or immunosuppression |
03/23/2011 | EP2297303A2 Cell membrane engineering |
03/23/2011 | EP2297302A1 Method of inducing proliferation and/or differentiation of neural precursor cells by introducing prolactin or wnt3a to activate latent neural precursor cells |
03/23/2011 | EP2297300A1 Generation of induced pluripotent stem (ips) cells |
03/23/2011 | EP2297299A1 Methods for preparing human skin substitutes from human pluripotent stem cells |
03/23/2011 | EP2297298A2 Pancreatic endocrine progenitor cells derived from pluripotent stem cells |
03/23/2011 | EP2297193A1 Histamine binding protein |
03/23/2011 | EP2297185A1 Parvoviral capsid with incorporated gly-ala repeat region |
03/23/2011 | EP2296701A1 Cell-based systems for producing influenza vaccines |
03/23/2011 | EP2296674A2 Novel adult progenitor cell |
03/23/2011 | EP2296672A1 Conditioned medium of liver progenitor cells |
03/23/2011 | EP2296478A1 Brown adipocyte progenitors in human skeletal muscle |
03/23/2011 | EP1896044B1 Bone formation composition composed of mixture of osteoblast and bio-matrix and its manufacturing method |
03/23/2011 | EP1815001B8 Gene trap cassettes for random and targeted conditional gene inactivation |
03/23/2011 | EP1773987B1 Stem cells obtained from pulp of deciduous or permanent teeth and of dental germ, able to produce human bone tissue |